- ¥177bn
- ¥185bn
- ¥27bn
Q1 group results (IFRS)
2025 group results (IFRS)
2025 group forecast(IFRS)
9-MTH group results (IFRS)
Table: GNI Group 6-MTH group results (IFRS)
Q1 group results (IFRS)
2024 group results (IFRS)
2024 group results (IFRS)
9-MTH group results (IFRS)
Q1 group results (IFRS)
2023 group results (IFRS)
2023 group forecast(IFRS)
9-MTH group results (IFRS)
2023 group forecast(IFRS)
To Purchase Elutia's Orthobiologics Business For $15 Million In Advance, With Additional Royalties Of Up To $20 Million Over Next 5 Years
6-MTH group results (IFRS)
2023 group forecast(IFRS)
Q1 group results (IFRS)
2022 group results (IFRS)